Related Books
Language: en
Pages: 240
Pages: 240
Type: BOOK - Published: 2001 - Publisher: Edward Elgar Publishing
Almost 90 per cent of new drugs are unavailable in Japan. This book presents an analysis of the nature, causes and consequences of this problem, contrasting the
Language: en
Pages: 245
Pages: 245
Type: BOOK - Published: 2011-03-02 - Publisher: Routledge
This book explores why Japan, despite being a world leader in many high technology industries such as automobiles and consumer electronics, is only a minor play
Language: en
Pages: 297
Pages: 297
Type: BOOK - Published: 2011-12-29 - Publisher: Trafford Publishing
It's Worth Doing is a must read for anyone engaged in cross-border dealings with Japan in the pharmaceutical industry. This book offers a wealth of insight that
Language: en
Pages: 252
Pages: 252
Type: BOOK - Published: 2022-02-08 - Publisher: Springer Nature
This is the first book published that focuses on competition law and policy in the Japanese pharmaceutical sector. It consists of chapters written and edited by
Language: en
Pages: 326
Pages: 326
Type: BOOK - Published: 2013-01-25 - Publisher: Trafford Publishing
They Do Well Who Do Good is a collection of articles written from 2000 to 2010 that document the changes in the Japan health care system and pharma industry. Ch
